Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma.

The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma. Abstract Text:

    zan shenZan Shen,zhen fan yangZhen Fan Yang,yi gaoYi Gao,ji cheng liJi Cheng Li,hai xiao chenHai Xiao Chen,ching chiu liuChing Chiu Liu,ronnie t p poonRonnie T P Poon,sheung tat fanSheung Tat Fan,john m lukJohn M Luk,kong hung szeKong Hung Sze,tsai ping liTsai Ping Li,ren bao ganRen Bao Gan,ming liang heMing Liang He,hsiang fu kungHsiang Fu Kung,marie c m linMarie C M Lin,zan shenZan Shen,zhen fan yangZhen Fan Yang,yi gaoYi Gao,ji cheng liJi Cheng Li,hai xiao chenHai Xiao Chen,ching chiu liuChing Chiu Liu,ronnie t p poonRonnie T P Poon,sheung tat fanSheung Tat Fan,john m lukJohn M Luk,kong hung szeKong Hung Sze,tsai ping liTsai Ping Li,ren bao ganRen Bao Gan,ming liang heMing Liang He,hsiang fu kungHsiang Fu Kung,marie c m linMarie C M Lin,

    The kringle 1 domain of human hepatocyte growth factor (HGFK1) was previously shown to inhibit bovine aortic endothelial cell proliferation, suggesting that it might be an antiangiogenic molecule. Here, we evaluated the in vivo efficacy of a recombinant adenoassociated virus carrying HGFK1 (rAAV-HGFK1) for the treatment of hepatocellular carcinoma (HCC) in a rat orthotopic HCC model and explored its molecular mechanisms in vitro in both endothelial and tumor cells. We first showed that rAAV-HGFK1 treatment significantly prolonged the survival time of rats transplanted with tumor cells. Treatment with rAAV-HGFK1 inhibited tumor growth, decreased tumor microvessel density, and completely prevented intrahepatic, lung, and peritoneal metastasis in this in vivo model. In vitro, rAAV-HGFK1 exhibited both antiangiogenic and antitumor cell effects, inhibiting the proliferation of both murine microvascular endothelial cells (MEC) and tumor cells, and inducing apoptosis and G(0)-G(1) phase arrest in these cells. To our surprise, rAAV-HGFK1 did not act through the hepatocyte growth factor/hepatocyte growth factor receptor pathway. Instead, it worked mainly through epidermal growth factor (EGF)/epidermal growth factor receptor (EGFR) signaling, with more minor contributions from vascular endothelial growth factor/vascular endothelial growth factor receptor and beta fibroblast growth factor (bFGF)/beta fibroblast growth factor receptor (bFGFR) signaling. In both MECs and tumor cells, rAAV-HGFK1 acted through two pathways downstream of EGFR, namely inhibition of extracellular signal-regulated kinase activation and stimulation of p38 mitogen-activated protein kinase/c-Jun-NH(2)-kinase activation. These results suggest for the first time that HGFK1 exerts both antiangiogenic and antitumor cell activities mainly through EGF/EGFR signaling, and may thus be considered as a novel therapeutic strategy for the treatment of HCC.

    The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma. Publishing Authors By Initials

    z shenZ Shen,zf yangZF Yang,y gaoY Gao,jc liJC Li,hx chenHX Chen,cc liuCC Liu,rt poonRT Poon,st fanST Fan,jm lukJM Luk,kh szeKH Sze,tp liTP Li,rb ganRB Gan,ml heML He,hf kungHF Kung,mc linMC Lin,z shenZ Shen,zf yangZF Yang,y gaoY Gao,jc liJC Li,hx chenHX Chen,cc liuCC Liu,rt poonRT Poon,st fanST Fan,jm lukJM Luk,kh szeKH Sze,tp liTP Li,rb ganRB Gan,ml heML He,hf kungHF Kung,mc linMC Lin,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Cancer research

    VOLUME: 68

    Page Numbers: 404-14

    Journal Abbreviation: Cancer Res.

    ISSN: 1538-7445

    DAY: 15

    MONTH: Jan

    YEAR: 2008

    The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2984705

    The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma.

    AFFILIATION: Institute of Molecular Biology, Department of Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, China.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News